Published within
|«
«
|
1
|
2
|
3
|
4
|
5
|
6
|
»
»|
| Type |
Product title / description
|
Pub
|
Price |
Company Profile
|
Vectura Group (Vectura or 'the group') is engaged in the development of inhaled therapies for the treatment of respiratory diseases. The group operates in the UK, where it is headquartered in Wiltshire. Vectura employed 209 people as of March 31, 2012.
Published By MarketLine
|
07 Mar 2013 |
$175
|
Company Profile
|
UCB S.A. (UCB or 'the company') is a global biopharmaceutical company. The company focuses on development and marketing of therapies for severe diseases in the fields of central nervous system (CNS) disorders and autoimmune and inflammatory diseases (AIID). It has operations in about 40 countries in Europe, North America, Asia, Africa, Oceania and South America. It is headquartered in Brussels, Belgium, and employed 8,506 people as of December 31, 2011.
Published By MarketLine
|
02 Jan 2013 |
$175
|
Company Profile
|
Teva Pharmaceutical Industries (Teva or 'the company') is the world's leading generic pharmaceutical company. Teva is engaged in the development, production and marketing of generic, proprietary branded pharmaceuticals and active pharmaceutical ingredients (APIs). The company conducts its operations in the Americas, Europe, Asia and other regions of the world. Teva is headquartered in Petach Tikva, Israel, and employed 45,754 people as on December 31, 2011.
Published By MarketLine
|
28 Sep 2012 |
$175
|
Company Profile
|
Takeda Pharmaceutical Company Limited (Takeda or 'the company') is a research-based global company with its main focus on pharmaceuticals. The company markets its products in about 100 countries. It is headquartered in Osaka, Japan and employed 30,305 people as of March 31, 2012.
Published By MarketLine
|
28 Feb 2013 |
$175
|
Company Profile
|
Shire (or 'the company') is a global specialty biopharmaceutical company. The company operates in North America, Europe and other countries. It is headquartered in Dublin, Republic of Ireland and employed 5,251 people as on December 31, 2011.
Published By MarketLine
|
27 Nov 2012 |
$175
|
Company Profile
|
Shionogi & Co. (Shionogi or 'the group') is engaged in the research, development, manufacture, and marketing of ethical drugs, over-the-counter drugs and diagnostic products. Shionogi primarily operates in Japan, Europe and North America. It is headquartered in Osaka, Japan, and employed 6,132 people as of March 31, 2012.
Published By MarketLine
|
24 May 2013 |
$175
|
Company Profile
|
Sanofi (or 'the group'), formerly Sanofi-Aventis, is a France-based international pharmaceutical group engaged in the research, development, manufacture and marketing of healthcare products. It offers biopharmaceuticals, human vaccines and animal and consumer health products. The group operates in more than 100 countries. It is headquartered in Paris, France, and employed 113,719 people as of December 31, 2011.
Published By MarketLine
|
30 Oct 2012 |
$175
|
Company Profile
|
Sandoz International GmbH (Sandoz or 'the company'), the generic business division of Novartis, is the second largest generic manufacturer (in terms of revenues) in the world. It is engaged in the development, manufacture and marketing of generic medicines as well as pharmaceutical and biotechnological active ingredients. The company manufactures more complex generics in different delivery systems including patches, injectables and inhalers. It has operations in more than 130 countries. It is headquartered
Published By MarketLine
|
22 Jun 2012 |
$175
|
Company Profile
|
Rigel Pharmaceuticals (Rigel or 'the company') is a clinical-stage drug development company engaged in the discovery and development of small-molecule drugs for the treatment of inflammatory and autoimmune disorders, as well as muscle disorders. The company operates in the US, where it is headquartered in South San Francisco, California. It employed 153 people as of December 31, 2011.
Published By MarketLine
|
07 Dec 2012 |
$175
|
Company Profile
|
Recordati S.p.A. (Recordati or 'the company') is a mid-sized European pharmaceutical company marketing ethical pharmaceuticals, most of which have been in-licensed for development and marketing within specific European markets. The company markets its products in more than 100 countries, primarily in the EU. It is headquartered in Milan, Italy, and employed 3,200 people as of December 31, 2011.
Published By MarketLine
|
28 Dec 2012 |
$175
|
|«
«
|
1
|
2
|
3
|
4
|
5
|
6
|
»
»|
No help is available.
Reports and briefs contain analyst driven analysis and opinion covering a specific market or issue.
Business Insight reports are an objective source of data, analysis and market insight
Insight for technology vendors into customer trends and pain points from key business decision makers.
Butler Group's thought leadership, opinion, with end user case studies and product profiles for key vendors.
Butler Group's vendor ranking and assessment model groups vendors into Outperform, Perform, and Under-perform categories.
Butler Group's thought leadership, opinion, and best practice with technology audits, product comparisons and rankings.
Opinion and market commentary from Datamonitor's industry experts.
Company profiles deliver detailed insight into how companies are organized and function with SWOT analysis.
Company reports provide detailed company evaluations.
Opinion and market commentary from Datamonitor's industry experts.
Company reports provide detailed company evaluations.
Opinion and market commentary from Datamonitor's industry experts.
Opinion and market commentary from Datamonitor's industry experts.
Track industry events, markets, products, customers, prospects, competitors and partners
Country profiles presenting easy-to-digest summaries and standardized data.
Databooks use charts and tables to provide a data-centric view of a particular market or category
Opinion and market commentary from Datamonitor's industry experts.
Comprehensive category data, including market value, volume, segmentation and share, with analysis.
Industry profiles provide standardized market data (including size & segmentation) and competitive analysis.
Market sizing and forecast data for a market or sector delivered in spreadsheet format.
Track industry events, markets, products, customers, prospects, competitors and partners
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Reports and briefs contain analyst driven analysis and opinion covering a specific market or issue.
Opinion and market commentary from Datamonitor's industry experts.
Insight for technology vendors into customer trends and pain points from key business decision makers.
Business information covering a specific market or issue.